Table 2.
The relationship between TP and the risk of HCV infection
| Variables | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
|
|
|
|
||||
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
| TP | 1.06 (1.01-1.11) | 0.030 | 1.06 (1.01-1.11) | 0.032 | 1.05 (0.98-1.13) | 0.149 |
| TP (median) | ||||||
| 1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
| 2 | 2.07 (1.03-4.15) | 0.042 | 2.23 (1.06-4.69) | 0.035 | 1.79 (0.58-5.52) | 0.314 |
| P for trend | 0.042 | 0.035 | 0.314 | |||
Model 1: Crude, Model 2: Adjust: gender, age, Model 3: Adjust: gender, age, HCV-Ab, ALT, AST, mAST, GGT, AG. OR, Odds Ratio; CI, Confidence Interval; TP, total protein; HCV-Ab, hepatitis C virus antibody; ALT, alanine aminotransferase; AST, aspartate aminotransferase; mAST, mitochondrial aspartate aminotransferase isoenzyme; GGT, gamma-glutamyl transferase; A/G, albumin-to-globulin ratio.